The Future of Pharmaceuticals
A Nonlinear Analysis
- Available for pre-order. Item will ship after October 25, 2021
Before now, biological systems could only be expressed in terms of linear relationships, however, as knowledge grows and new techniques of analysis on biological systems is made available, we are realizing the non-linearity of these systems. The concepts and techniques of nonlinear analysis allow for more realistic and accurate models in science. The Future of Pharmaceuticals: A Nonlinear Analysis provides an opportunity to understand the non-linearity of biological systems and its application in various areas of science, primarily pharmaceutical sciences. This book will benefit professionals in pharmaceutical industries, academia, and policy who are interested in an entirely new approach to how we will treat disease in the future.
- Addresses a new approach of nonlinear analysis.
- Applies a theory of projection to chalk out the future, instead of basing on linear evolution. Provides an opportunity to better understand the non-linearity in biological systems and its applications in various areas of science, primarily pharmaceutical sciences.
- Helps change the thought process for those looking for answers to their questions which they do not find in the linear relationship approach.
- Encourages a broader perspective for the creative process of drug development.
Table of Contents
Glossary of Terms
Chapter 1 Understanding Nonlinearity
Chapter 2 Evolution of Pharmaceuticals
Chapter 3 Artificial Intelligence
Chapter 4 Drug Discovery Trends
Chapter 5 Drug Development Assays
Chapter 6 Nanotechnology
Chapter 7 Antimicrobials
Chapter 8 Therapeutic Proteins
Chapter 9 Manufacturing Trends
Chapter 10 Therapeutic Proteins Delivery Systems
Chapter 11 Gene and Cell Therapy
Chapter 12 Nucleic Acid Vaccines
Chapter 13 Botanical Products
Chapter 14 Regulatory Optimization
Chapter 15 Intellectual Property
Sarfaraz K. Niazi is a well-recognized authority on drug and dosage form development including biological drugs and alternative medicines. He has published over 100 research articles, dozens of major books in pharmaceutical technology and owns 100+ patents in bioprocessing, new drug development, analytical testing, and novel treatments. He has hands on experience in developing chemical, botanical and biological products, from discovery to regulatory approval. He currently serves as Adjunct Professor at the University of Illinois College of Pharmacy, and several other institutions across globe. Professor Niazi serves as an advisory to several regulatory agencies, including the FDA, and inductee in the Entrepreneur Hall of Fame to introducing novel biotechnologies to develop medicines. He is a fellow of several prestigious scientific academies.